β-Galactosidosis in Patient with Intermediate GM1 and MBD Phenotype.

[1]  Y. Satow,et al.  Crystal structure of human beta-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases , 2011 .

[2]  Y. Satow,et al.  Crystal Structure of Human β-Galactosidase , 2011, The Journal of Biological Chemistry.

[3]  E. Bertini,et al.  GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. , 2011, Biochimica et biophysica acta.

[4]  B. Plecko,et al.  Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations , 2010, Clinical genetics.

[5]  K. Ikeda,et al.  Structural bases of GM1 gangliosidosis and Morquio B disease , 2009, Journal of Human Genetics.

[6]  U. Ramaswami,et al.  GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid β‐galactosidase , 2009, Human mutation.

[7]  R. Giugliani,et al.  New GLB1 mutation in siblings with Morquio type B disease presenting with mental regression. , 2009, Molecular genetics and metabolism.

[8]  Nicola Brunetti-Pierri,et al.  GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. , 2008, Molecular genetics and metabolism.

[9]  J. Callahan,et al.  Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients Published, JLR Papers in Press, July 30, 2007. , 2007, Journal of Lipid Research.

[10]  D. Grinberg,et al.  Twenty‐one novel mutations in the GLB1 gene identified in a large group of GM1‐gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies , 2006, Human mutation.

[11]  E. Zammarchi,et al.  Primary and secondary elastin-binding protein defect leads to impaired elastogenesis in fibroblasts from GM1-gangliosidosis patients. , 2005, The American journal of pathology.

[12]  M. Vidailhet,et al.  Dystonia and parkinsonism in GM1 type 3 gangliosidosis , 2005, Movement disorders : official journal of the Movement Disorder Society.

[13]  J. Callahan,et al.  Novel mutations (Asn 484 Lys, Thr 500 Ala, Gly 438 Glu) in Morquio B disease. , 2002, Biochimica et biophysica acta.

[14]  H. Kreimer-Erlacher,et al.  Mutation analyses in 17 patients with deficiency in acid β-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B , 2001, Human Genetics.

[15]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[16]  E. Zammarchi,et al.  β‐galactosidase gene mutations affecting the lysosomal enzyme and the elastin‐binding protein in GM1‐gangliosidosis patients with cardiac involvement , 2000, Human mutation.

[17]  J. Callahan.  Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. , 1999, Biochimica et biophysica acta.

[18]  R. Stevenson,et al.  β-Galactosidase Gene Mutations in Patients With Slowly Progressive GM1 Gangliosidosis , 1997, Journal of child neurology.

[19]  S. Withers,et al.  Identification of Glu-268 as the Catalytic Nucleophile of Human Lysosomal β-Galactosidase Precursor by Mass Spectrometry* , 1997, The Journal of Biological Chemistry.

[20]  F. Endo,et al.  Clinical and molecular analysis of a Japanese boy with Morquio B disease , 1995, Clinical genetics.

[21]  P. Benson,et al.  Progressive mental regression in siblings with Morquio disease Type B (mucopolysaccharidosis IV B) , 1987, Clinical genetics.